Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers

AIDS

Volumn 19, Issue 10, 2005, Pages 1071-1079

  Bunders, Madeleine ^a,b   Thorne, Claire ^a   Newell, Marie Louise ^a,b   Giaquinto, C ^c   Rampon, O ^c   De Rossi, A ^c   Grosch Worner I ^c   Mok, J ^c   Bates, I ^c   de Jose I ^c   Hawkins, F ^c   Garcia Rodriguez, M C ^c   Ladron de Guevara C ^c   Ma Pena J ^c   Gonzalez Garcia, J ^c   Arribas Lopez, J R ^c   Asensi Botet, F ^c   Otero, M C ^c   Perez Tamarit D ^c   Orti, A ^c   San Miguel, M J ^c   de la Torre, R ^c   Scherpbier, H ^c   Kreyenbroek, M ^c   Boer, K ^c   Bohlin, A B ^c   Belfrage, E ^c   Naver L ^c   Levy, J ^c   Hainaut, M ^c   Peltier, A ^c   Goetghebuer, T ^c   Barlow, P ^c   Ferrazin, A ^c   Bassetti, D ^c   De Maria, A ^c   Gotta, C ^c   Mur A ^c   Lopez Vilchez M A ^c   Paya A ^c   Carreras, R ^c   Valerius, N H ^c   Niemec T ^c   Marczynska, M ^c   Oldakowska, A ^c   Kaflik, M ^c   Vigno, A ^c   Giacomet, V ^c   Buffolano, W ^c   Vegnente, A ^c   Iorio, R ^c   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c University College London ^*

Author keywords

Antiretroviral treatment; Gender; Haematopoiesis; Race; Uninfected children

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; PROTEINASE INHIBITOR; ZIDOVUDINE;

ARTICLE; CELL COUNT; CHILD; CONTROLLED STUDY; DRUG EXPOSURE; DRUG WITHDRAWAL; ENVIRONMENTAL EXPOSURE; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LINEAR REGRESSION ANALYSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREMATURITY; PRIORITY JOURNAL; RACE DIFFERENCE; SCORING SYSTEM; T LYMPHOCYTE; VERTICAL TRANSMISSION;

EID: 21844444330     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000174454.63250.22     Document Type: Article

References (31)

1. Mandelbrot L, Landreau A, Rekacewicz C, Berribi A, Benifla JL, Burgard M, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001; 285:2083-2093.
2. European Collaborative Study. Are girls more at risk of intra-uterine-acquired HIV infection than boys? AIDS 2004; 18:344-347.
3. Mofenson LM, Munderi P. Safety of antiretroviral prophylaxis of perinatal transmission for HIV-Infected pregnant women and their infants. AIDS 2002; 30:200-215.
4. Blanche S, Tardieu M, Rustin P, Stama A, Firtion G, Giraru-Vigneron N, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999; 354:1084-1089.
5. Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S. Perinatal antiretroviral treatment and hematopoiesis in HIV - uninfected infants. AIDS 2003; 17:2053-2061.
6. European Collaborative Study. Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1 infected mothers. AIDS 2004; 18:2009-2017.
7. Janeway CA, Travers P, Walport M, Shlomchick M. Immunobiology, The Immune System in Health and Disease. 5th edn. New York: Garland; 2001.
8. European Collaborative Study. HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS 2001; 15:761-770.
9. European Collaborative Study. Are there gender and race differences in cellular immunity patterns over age in infected and uninfected children born to HIV-infected women? J Acquir Immune Defic Syndr 2003; 33:635-641.
10. Stiehm ER, Ochs HD, Winkelstein JA. Immunologic Disorders in Children. 5th edn. Philadelphia, PA: Elsevier/Saunders; 2004.
11. World Health Organization. Treat 3 Million by 2005. Geneva: World Health Organization; 2003; 31-39. http://www.who.int/ hiv/pub/prev_care/en/ arvrevision2003en.pdf
12. Centers For Disease Control and Prevention. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Bethesda, MD Centers For Disease Control and Prevention HIV/AIDS Treatment Information Service; 2001.
13. Ammann A. Pediatric human immunodeficiency virus infection. In: lmmunological Disorders in Children. Edited by Stiehm ER, Ochs HD, Winkelstein JA. Philadelphia, PA: Elsevier/ Saunders; 2004. pp. 878-951.
14. Lugada ES, Mermin JH, Kaharuza F. Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diag Lab Immunol 2004:29-34.
15. Shearer WT, Rosenblatt HM, Gelman R, Oyomopito R, Plaeger S, Stiehm ER, et al. for the Pediatric AIDS Clinical Trials Group. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 Study. J Allergy Clin Immunol 2003:973-980.
16. Uppal SS, Tewari SC, Verma S, Dhot PS. Comparison of CD4 and CD8 lymphocyte counts in HIV-negative TB patients with those in normal blood donors and the effect of antitubercular treatment: hospital-based flow cytometric study. Clin Cytometry 2004; 61:20-26.
17. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992; 11:1305-1319.
18. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38:963-974.
19. Akaike H. A new look at statistical model identification. IEEE Trans 1974; AU-19:716-722.
20. Kalbfleish JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: Wiley; 2004.
21. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman & Hall; 1984.
22. European Collaborative Study. Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr 2003; 32:380-387.
23. Shah MM, Li Y, Christensen RD. Effects of perinatal zidovudine on hematopoiesis: a comparison of effects on progenitors from human fetuses versus mothers. AIDS 1996; 10:1239-1247.
24. Nielsen SD, Jeppesen DL, Kolte L, Clark DR, Sorensen TU, Dreves AM, et al. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 2001; 98: 398-404.
25. Dainiak N, Worthington M, Riordan MA. 3′-Azido-3′- deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol 1988; 69: 299-304.
26. Mandelbrot L, Peytavin G, Firtion G, Farinotti R. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women. Am J Obstet Cynecol 2001; 184:153-158.
27. Olivero OA, Shearer GM, Chouquet CA, Kovacs A, Baker R, Stek AM, et al. Corporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1 positive mothers. Ann N Y Acad Sci 2000; 918:262-268.
28. Luzuriaga K, Sullivan J. Prevention of mother-to-child transmission of HIV Infection. Clin Infect Dis 2005; 30:466-467.
29. Bohler T, Walcher J, Holzl-Wenig G, Geiss M, Buchholz B, Linde R, et al. Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents. AIDS 1999; 13:779-789.
30. Trabattoni D, Piconi S, Biasin M, Rizzrdini C, Migliorino M, Seminari E, et al. Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals. AIDS 2004; 18:859-869.
31. European Collaborative Study, The Swiss Mother and Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS 2000; 14:2913-2920.